In a previous study, ERK1/2 has been demonstrated to contribute to the transformation of MDS into AML.[40] Therefore, we inferred that the downregulation of miR-550a-3p might promote the progression of MDS by upregulating ERK1/2. This evidence concerns the gene MAPK3 and acute myeloid leukemia.